Filtros de búsqueda

Lista de obras de

1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults

2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain

artículo científico publicado en 2019

A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection

article

A century of influenza prevention in St. Louis

artículo científico publicado en 2012

A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

scientific article published on 01 February 1996

A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination

artículo científico publicado en 1999

A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans

artículo científico publicado en 2013

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

artículo científico publicado en 2009

A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates

artículo científico publicado en 2000

A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants

artículo científico publicado en 2003

A phase I safety and immunogenicity dose escalation trial of plague vaccine, Flagellin/F1/V, in healthy adult volunteers (DMID 08-0066).

artículo científico publicado en 2017

A review of adenoviruses in the etiology of acute hemorrhagic cystitis

artículo científico publicado en 1976

A review of attenuation of influenza viruses by genetic manipulation

artículo científico publicado en 1995

A single-season epidemic with respiratory syncytial virus subgroup B2 during 10 epidemic years, 1978 to 1988.

artículo científico publicado en 1991

A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.

artículo científico publicado en 2016

A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection

artículo científico publicado en 2011

AIDS: the significance of anti-HTLV-III antibodies.

artículo científico publicado en 1985

Acellular pertussis vaccines in infants: evaluation of single component and two-component products

artículo científico publicado en 1994

Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children.

artículo científico publicado en 1982

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

artículo científico publicado en 1998

Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response

artículo científico publicado en 2010

Aging-dependent alterations in gene expression and a mitochondrial signature of responsiveness to human influenza vaccination.

artículo científico publicado en 2015

An altered relationship of influenza vaccine-specific IgG responses with T cell immunity occurs with aging in humans

artículo científico publicado en 2013

An introduction to influenza: lessons from the past in epidemiology, prevention, and treatment.

artículo científico publicado en 2008

An introduction: contemporary topics in infection control

artículo científico publicado el 1 de abril de 1981

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group

artículo científico publicado en 1998

Analysis of reversions in the 5'-untranslated region of attenuated poliovirus after sequential administration of inactivated and oral poliovirus vaccines

artículo científico publicado en 2006

Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines

artículo científico publicado en 2012

Antibody responses to vaccinia membrane proteins after smallpox vaccination

artículo científico publicado en 2007

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

artículo científico publicado en 1996

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1993

Benefits and risks of live attenuated influenza vaccine in young children

artículo científico publicado en 2010

Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine

artículo científico publicado en 2014

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

artículo científico publicado en 2004

Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160

artículo científico publicado en 2004

Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production.

artículo científico publicado en 2001

Cause of acute hemorrhagic cystitis in children

Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine

artículo científico publicado en 2015

Characteristics of a population volunteering for human immunodeficiency virus immunization. NIAID AIDS Clinical Trials Network

artículo científico publicado en 1990

Characterization by Hemagglutination-Inhibition of Adenovirus 11 Strains from Urine of Patients with Hemorrhagic Cystitis

artículo científico publicado el 1 de julio de 1973

Characterization of a live, attenuated human parainfluenza type 3 virus candidate vaccine strain.

artículo científico publicado en 1995

Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.

artículo científico publicado en 2010

Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection

artículo científico publicado en 2005

Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient

artículo científico publicado en 1988

Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge

artículo científico publicado en 2007

Clinical and serologic responses to acellular pertussis vaccine in infants and young children.

artículo científico publicado en 1987

Clinical responses to undiluted and diluted smallpox vaccine

artículo científico publicado en 2002

Cold adaptation of parainfluenza virus type 3: Induction of three phenotypic markers ⬇️

artículo científico publicado el 1 de enero de 1982

Cold-passaged human parainfluenza type 3 viruses contain ts and non-ts mutations leading to attenuation in rhesus monkeys ⬇️

artículo científico publicado el 1 de marzo de 1992

Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge

artículo científico publicado en 1984

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

artículo científico publicado en 2007

Comparison of enzyme-linked immunosorbent assay and neutralization techniques for measurement of antibody to respiratory syncytial virus: implications for parenteral immunization with live virus vaccine

artículo científico publicado en 1982

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects

artículo científico publicado en 2015

Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illness

artículo científico publicado en 2007

Comparison of the immune response to recombinant gp120 in humans and chimpanzees

artículo científico publicado en 1994

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

artículo científico publicado en 2011

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

artículo científico publicado en 2000

Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults

artículo científico publicado en 2016

Correlate of immune protection against HSV-1 genital disease in vaccinated women

artículo científico publicado en 2013

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

artículo científico publicado en 2000

Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays

scientific article published on 04 April 2019

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children

artículo científico publicado en 2001

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States

artículo científico publicado en 2008

Current progress in HIV vaccines

artículo científico publicado el 1 de noviembre de 1991

Current status of live attenuated influenza virus vaccine in the US.

artículo científico publicado en 2004

Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group.

artículo científico publicado en 2000

Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120.

artículo científico publicado en 2001

DNA priming for seasonal influenza vaccine: a phase 1b double-blind randomized clinical trial

artículo científico publicado en 2015

Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Networ

artículo científico publicado en 1992

Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1994

Development of a high-throughput β-Gal-based neutralization assay for quantitation of herpes simplex virus-neutralizing antibodies in human samples

artículo científico publicado en 2016

Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants

artículo científico publicado en 1988

Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants

scientific article published on 01 August 1992

Dose-dependent neutralizing-antibody responses to vaccinia

artículo científico publicado en 2004

Dose-related effects of smallpox vaccine

artículo científico publicado en 2002

Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine

artículo científico publicado en 1993

Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.

artículo científico publicado en 1994

Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.

artículo científico publicado en 2005

Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children

artículo científico publicado en 2003

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

artículo científico publicado en 1999

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

artículo científico

Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity

artículo científico publicado en 2014

Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.

scientific article published on May 2010

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity

artículo científico publicado en 2009

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

artículo científico publicado en 2000

Efficacy results of a trial of a herpes simplex vaccine

artículo científico publicado en 2012

Emergence and apparent transmission of rimantadine-resistant influenza A virus in families

artículo científico publicado en 1989

Enhanced lymphoproliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses

artículo científico publicado en 1991

Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults

artículo científico publicado en 1990

Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection ⬇️

artículo científico publicado el 1 de junio de 1978

Epidemiology of severe respiratory syncytial virus infections in Huntington, West Virginia

artículo científico publicado en 1981

Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women

artículo científico publicado en 2012

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

artículo científico publicado en 2000

Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children ⬇️

artículo científico publicado el 1 de septiembre de 1992

Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children ⬇️

artículo científico publicado el 1 de agosto de 1992

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

artículo científico publicado en 2000

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

artículo científico publicado en 1996

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults

artículo científico publicado en 2002

Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees.

artículo científico publicado en 1991

Evaluation of cold-adapted adn temperature-sensitive mutants of parainfluenza virus type 3 in weanling hamsters ⬇️

artículo científico publicado el 1 de enero de 1984

Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants

artículo científico publicado en 1989

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children

artículo científico publicado en 2004

Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: I. Viral shedding, immunologic response, and associated illness ⬇️

artículo científico publicado el 1 de enero de 1978

Evaluation of five temperature-sensitive mutants of respiratory syncytial virus in primates: II. Genetic analysis of virus recovered during infection ⬇️

artículo científico publicado el 1 de enero de 1978

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza

artículo científico publicado en 1996

Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children

scientific article published on 01 May 1986

Evaluation of smallpox vaccines using variola neutralization

artículo científico publicado en 2009

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

artículo científico publicado en 1999

Experimental respiratory syncytial virus infection of four species of primates ⬇️

artículo científico publicado el 1 de enero de 1977

Experimental respiratory syncytial virus pneumonia in cebus monkeys ⬇️

artículo científico publicado el 1 de enero de 1978

Fatal coxsackievirus B4 infection in a neonate

artículo científico publicado en 1985

Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions

artículo científico publicado en 2005

From the National Institutes of Health: report of a workshop on respiratory syncytial virus and parainfluenza viruses

artículo científico publicado en 1978

Further characterization of the complementation group B temperature-sensitive mutant of respiratory syncytial virus ⬇️

artículo científico publicado el 1 de octubre de 1977

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection

artículo científico publicado en 1988

Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine

artículo científico publicado en 2010

Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization.

artículo científico

Glycosylations in the globular head of the hemagglutinin protein modulate the virulence and antigenic properties of the H1N1 influenza viruses

artículo científico publicado en 2013

Growth and genetic stability of 4 temperature sensitive (ts) mutants of respiratory syncytial (RS) virus in newborn ferrets

artículo científico publicado el 1 de enero de 1978

Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens

artículo científico publicado en 1990

HIV infection in vaccinated volunteers.

artículo científico publicado en 1994

HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers.

artículo científico publicado en 2001

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1994

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 February 1995

HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

artículo científico publicado en 1999

HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).

artículo científico publicado en 2014

Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses

artículo científico publicado en 2012

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses

artículo científico publicado en 2015

Human-rhesus reassortant rotavirus vaccines: safety and immunogenicity in adults, infants, and children

artículo científico publicado en 1988

Identification by immunofluorescence of adenoviral antigen in exfoliated bladder epithelial cells from patients with acute hemorrhagic cystitis

artículo científico publicado en 1974

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

artículo científico publicado en 2005

Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guérin

artículo científico publicado en 1996

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

artículo científico publicado en 1998

Immune responses to plasmid DNA encoding the hepatitis C virus core protein ⬇️

artículo científico publicado el 1 de septiembre de 1995

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine

artículo científico publicado el 1 de abril de 1992

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Ev

artículo científico publicado en 1996

Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children

artículo científico publicado en 2012

Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trial

artículo científico

Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children

artículo científico publicado en 1993

Immunoprophylaxis of pneumococcal pneumonia

artículo científico publicado en 1979

Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus

artículo científico publicado en 2001

Impact of removing gentamicin from an antibiotic restriction program

artículo científico publicado en 1985

Impact of viral respiratory diseases on infants and young children in a rural and urban area of southern West Virginia

artículo científico publicado en 1983

Implications of the emergence of a novel H1 influenza virus

artículo científico publicado en 2009

Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine

artículo científico publicado en 2003

Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccine

scientific article published on 01 July 1993

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

artículo científico publicado en 2004

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group

artículo científico publicado en 1998

Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines.

artículo científico publicado en 1993

Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.

artículo científico publicado en 1998

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

artículo científico publicado en 1995

Influenza Vaccine in Young Children

artículo científico publicado en 2012

Influenza as a zoonosis: how likely is a pandemic?

artículo científico publicado en 1998

Influenza prevention and treatment: current practices and new horizons

scientific article published on 01 October 1999

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

artículo científico publicado en 2009

Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants

scientific article published on 01 March 1995

Interpreting HIV serodiagnostic test results in the 1990s: social risks of HIV vaccine studies in uninfected volunteers. NIAID AIDS Vaccine Clinical Trials Group

scientific article published on 01 October 1994

Isolation and characterization of further defective clones of a temperature sensitive mutant (ts-1) of respiratory syncytial virus

artículo científico publicado en 1977

Letter: Viral hemorrhagic cystitis

Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children

artículo científico publicado en 2011

Live attenuated influenza A virus vaccines in children: results of a field trial

artículo científico publicado en 1984

Live attenuated intranasal influenza vaccine

scientific article published on 01 October 2002

Live attenuated versus inactivated influenza vaccine in infants and young children.

artículo científico publicado en 2007

Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines

artículo científico publicado en 1988

Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado el 1 de enero de 1992

MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates. National Institute of Allergy and Infectious Disease Aids Vaccine Evaluation Group

artículo científico publicado en 1999

Male genital tuberculosis: a review of the literature with instructive case reports

artículo científico publicado en 1985

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis

artículo científico publicado en 2004

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

scientific article published on 01 March 1998

Molecular analyses and phylogeny of the herpes simplex virus 2 US9 and glycoproteins gE/gI obtained from infected subjects during the Herpevac Trial for Women

artículo científico publicado en 2019

Molecular evolution of herpes simplex virus 2 complete genomes: Comparison between primary and recurrent infections.

artículo científico publicado en 2017

Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses

artículo científico publicado en 2000

Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children

scientific article published on 01 May 1994

Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines

artículo científico publicado en 1997

Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network

scientific article published on 01 August 1994

New Concepts for Vaccines1.

artículo científico publicado en 2004

No clinical association of live attenuated influenza virus with nasal carriage of bacteria or acute otitis media

artículo científico publicado en 2014

Nosocomial influenza B virus infection in the elderly

artículo científico publicado en 1982

Occurrence, characteristics, and patterns of HIV-1 and HIV-2 western blot indeterminate sera in low risk populations in West Virginia and pre-AIDS Africa.

artículo científico publicado en 1990

Orally administered adenoviral-based vaccine induces respiratory mucosal memory and protection against RSV infection in cotton rats

artículo científico publicado en 2018

Palmitoylation of the influenza A virus M2 protein

artículo científico publicado en 1990

Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus

artículo científico publicado en 2010

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial

artículo científico publicado en 1982

Pharmacokinetics of a single dose of rimantadine in young adults and children

artículo científico publicado en 1987

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.

artículo científico publicado en 2010

Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

artículo científico publicado en 2004

Phase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals

artículo científico publicado en 2014

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

artículo científico publicado en 2014

Poxvirus zoonoses--putting pocks into context

artículo científico publicado en 2004

Prevaccine Determination of the Expression of Costimulatory B7 Molecules in Activated Monocytes Predicts Influenza Vaccine Responses in Young and Older Adults

article

Prevention of otitis media in children with live attenuated influenza vaccine given intranasally

artículo científico publicado en 2000

Priming Vaccination With Influenza Virus H5 Hemagglutinin Antigen Significantly Increases the Duration of T cell Responses Induced by a Heterologous H5 Booster Vaccination

artículo científico publicado en 2016

Progress toward the development of universal influenza vaccines.

artículo científico publicado en 2014

Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults

artículo científico publicado en 2014

Prospects for prevention of bronchiolitis caused by respiratory syncytial virus

artículo científico publicado el 1 de marzo de 1977

Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3.

artículo científico publicado en 1986

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans

article

Quadrivalent Ann Arbor strain live-attenuated influenza vaccine

artículo científico publicado en 2012

Rapid detection of parainfluenza virus type 3 RNA in respiratory specimens: use of reverse transcription-PCR-enzyme immunoassay.

artículo científico publicado en 1994

Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial

article

Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1995

Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization

artículo científico publicado en 2014

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

artículo científico publicado en 1991

Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D

artículo científico publicado en 2014

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance

artículo científico publicado en 1989

Respiratory syncytial virus antibodies in nonhuman primates and domestic animals

artículo científico publicado el 1 de agosto de 1981

Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986.

artículo científico publicado en 1988

Response to smallpox vaccine in persons immunized in the distant past

artículo científico publicado en 2003

Revaccination with pneumococcal and hepatitis B vaccines

artículo científico publicado en 1993

Role of virion M2 protein in influenza virus uncoating: specific reduction in the rate of membrane fusion between virus and liposomes by amantadine

artículo científico publicado en 1994

Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation Group ⬇️

artículo científico publicado el 20 de septiembre de 1997

Safety and Immunogenicity of a Single Low Dose or High Dose of Clade 2 Influenza A(H5N1) Inactivated Vaccine in Adults Previously Primed With Clade 1 Influenza A(H5N1) Vaccine.

artículo científico publicado en 2015

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

artículo científico publicado en 2008

Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent

artículo científico publicado en 2003

Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination

artículo científico publicado en 2004

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

artículo científico publicado en 2012

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

artículo científico publicado en 2010

Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario

artículo científico publicado en 2013

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

artículo científico publicado en 2001

Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.

artículo científico publicado en 1993

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects

artículo científico publicado en 2007

Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults

artículo científico publicado en 2009

Safety and immunogenicity of an inactivated hepatitis A vaccine: effect of dose and vaccination schedule

artículo científico publicado en 1994

Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant

artículo científico publicado en 2011

Safety and immunogenicity of investigational seasonal influenza hemagglutinin DNA vaccine followed by trivalent inactivated vaccine administered intradermally or intramuscularly in healthy adults: An open-label randomized phase 1 clinical trial

artículo científico publicado en 2019

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children

artículo científico publicado en 1998

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

artículo científico publicado en 1994

Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases

artículo científico publicado en 1986

Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children

artículo científico publicado en 2002

Safety profile of HIV vaccination: first 1000 volunteers of AIDS vaccine evaluation group. NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1994

Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children

artículo científico publicado en 2001

Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years

artículo científico publicado en 2004

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

artículo científico publicado en 2004

Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children

artículo científico publicado en 2001

Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group

artículo científico publicado en 1996

Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults

artículo científico publicado en 2020

Seroepidemiology of astrovirus MLB1

artículo científico publicado en 2014

Serological diagnosis of influenza B virus infection: comparison of an enzyme-linked immunosorbent assay and the hemagglutination inhibition test

scientific article published on May 1982

Serum antibody responses after intradermal vaccination against influenza

artículo científico publicado en 2004

Stability of Undiluted and Diluted Vaccinia‐Virus Vaccine, Dryvax ⬇️

artículo científico publicado el 2 de abril de 2003

Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

artículo científico publicado en 1994

Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.

artículo científico publicado en 1987

Superiority of live attenuated compared with inactivated influenza A virus vaccines in older, chronically ill adults

artículo científico publicado en 1991

Superiority of tissue-culture-grown antigens over egg-grown antigens for serologic diagnosis of influenza B virus infections

artículo científico publicado en 1986

Support for the RV144 HIV vaccine trial.

artículo científico publicado en 2004

Synthesis and antiviral activity of metabolites of rimantadine

artículo científico publicado en 1990

Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1[E] recombinant viruses in human adults

artículo científico publicado el 1 de agosto de 1977

Temperature-sensitive phenotype of the human parainfluenza virus type 3 candidate vaccine strain (cp45) correlates with a defect in the L gene

artículo científico publicado en 1996

The Potential of Live, Attenuated Influenza Vaccine for the Prevention of Influenza in Children

scientific article published on 01 August 2019

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

artículo científico publicado en 2007

The acquired immune deficiency syndrome in West Virginia: an 'imported' disease

artículo científico publicado el 1 de agosto de 1984

The burden of influenza and strategies for prevention

artículo científico publicado en 2007

The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination

artículo científico publicado en 2010

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

artículo científico publicado en 1998

The genetic archaeology of influenza

artículo científico publicado en 2004

The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.

artículo científico publicado en 2017

The immunogenetics of smallpox vaccination.

artículo científico publicado en 2007

The need for quadrivalent vaccine against seasonal influenza

artículo científico publicado en 2010

The origins of pandemic influenza--lessons from the 1918 virus.

artículo científico publicado en 2005

The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults

artículo científico publicado en 2011

The safety and efficacy of live attenuated influenza vaccine in young children with asthma or prior wheezing

artículo científico publicado en 2012

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1991

Translational research on vaccines: influenza as an example

artículo científico publicado en 2007

Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers

artículo científico publicado en 2005

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

artículo científico publicado el 1 de agosto de 1992

Vaccine-induced antibodies to heterologous influenza A H1N1 viruses: effects of aging and "original antigenic sin"

scientific article published on 01 May 1994

Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network

artículo científico publicado en 1994

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies

artículo científico publicado en 1999

Viral respiratory disease in the intensive care unit.

artículo científico publicado en 1986

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda